aml, adult

Showing 1 - 25 of 31

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

AML, Adult Trial (Pharmacoscopy, Clinical standard-of-care (physician's choice))

Not yet recruiting
  • AML, Adult
  • Pharmacoscopy
  • Clinical standard-of-care (physician's choice)
  • (no location specified)
Nov 20, 2023

AML, Adult, Minimal Residual Disease Trial (MRD assessment)

Not yet recruiting
  • AML, Adult
  • Minimal Residual Disease
  • MRD assessment
  • (no location specified)
Oct 13, 2023

AML, Adult, Minimal Residual Disease Trial in Guangzhou (chidamide and azacitidine)

Not yet recruiting
  • AML, Adult
  • Minimal Residual Disease
  • chidamide and azacitidine
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Sep 27, 2023

ALL, Adult, AML, Adult Trial (BN104)

Not yet recruiting
  • ALL, Adult
  • AML, Adult
  • (no location specified)
Sep 19, 2023

AML, Adult Trial in Hangzhou (CLL1 CAR-NK cell injection)

Recruiting
  • AML, Adult
  • CLL1 CAR-NK cell injection
  • Hangzhou, Zhejiang, China
    Clinical research ethics committee of the first affiliated hospi
Aug 30, 2023

AML, Adult, Refractory AML, Relapsed Adult AML Trial in France (AzaCITIDine Oral Tablet, Xospata)

Not yet recruiting
  • AML, Adult
  • +4 more
  • Amiens, France
  • +19 more
Sep 1, 2023

AML, Adult Trial in Netherlands (azacitidine, Venetoclax, Cobicistat)

Not yet recruiting
  • AML, Adult
  • Amersfoort, Netherlands
  • +17 more
Aug 23, 2023

AML, Adult, Minimal Residual Disease Trial in Tianjin (CD33/CLL1 dual CAR-NK cell, Cyclophosphamid, Fludarabine)

Not yet recruiting
  • AML, Adult
  • Minimal Residual Disease
  • CD33/CLL1 dual CAR-NK cell
  • +5 more
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Aug 4, 2023

AML, Adult Trial (STI-8591)

Not yet recruiting
  • AML, Adult
  • (no location specified)
Jul 12, 2023

Assessment of Geriatric Evaluations Impact on New AML Guidance

Not yet recruiting
  • AML, Adult
    • Philadelphia, Pennsylvania
      Abramson Cancer Center at University of Pennsylvania
    Jun 12, 2023

    AML, Adult Trial (Biological characterization of AML with MECOM or atypical 3q26 rearrangements)

    Not yet recruiting
    • AML, Adult
    • Biological characterization of AML with MECOM or atypical 3q26 rearrangements
    • (no location specified)
    Apr 21, 2023

    AML, Adult Trial in Hangzhou, Shanghai, Wuhan (Selinexor, Azacitidine, Venetoclax)

    Not yet recruiting
    • AML, Adult
    • Hangzhou, China
    • +3 more
    Feb 12, 2023

    AML, Adult Trial in Hangzhou (QN-023a, Cyclophosphamid, Fludarabine)

    Recruiting
    • AML, Adult
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Dec 29, 2022

    AML, Adult Trial in Hangzhou (QN-030a, Cyclophosphamid, Fludarabine)

    Recruiting
    • AML, Adult
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Dec 29, 2022

    AML, Adult Trial in Tianjin (QN-023a, Cyclophosphamid, Fludarabine)

    Recruiting
    • AML, Adult
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Nov 3, 2022

    AML, Adult Trial in Berne (HDM201, Midostaurin)

    Terminated
    • AML, Adult
    • Berne, Switzerland
      Departement of Medical Oncology, University Hospital Berne
    Oct 3, 2022

    AML, Adult Trial in Chicago, Charlottesville (BST-236, venetoclax)

    Recruiting
    • AML, Adult
    • Chicago, Illinois
    • +1 more
    Aug 17, 2022

    AML, Adult Trial in Australia, China, United States (APG 2575 ramp up arm)

    Recruiting
    • AML, Adult
    • APG 2575 ramp up arm
    • Baltimore, Maryland
    • +6 more
    Aug 12, 2022

    AML, Adult, MDS, Relapse/Recurrence Trial in United States (BST-236)

    Recruiting
    • AML, Adult
    • +3 more
    • Shreveport, Louisiana
    • +3 more
    Jul 19, 2022

    Acute Myeloid Leukemia, AML, Adult Trial in United States (evorpacept, venetoclax, azacitidine)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • AML, Adult
    • Chicago, Illinois
    • +4 more
    Jun 7, 2022

    Acute Myeloid Leukemia, AML, Adult, Multiple Myeloma Trial in United States (FT538, Cyclophosphamide, Fludarabine)

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Denver, Colorado
    • +8 more
    May 19, 2022

    Leukemia, Acute, AML, Adult, ALL, Adult Trial in Charlottesville (Palliative Care Visits)

    Recruiting
    • Leukemia, Acute
    • +3 more
    • Palliative Care Visits
    • Charlottesville, Virginia
      University of Virginia
    Apr 28, 2022

    Relapsed/Refractory AML, AML, Adult, MDS Trial in United States (NKX101 - CAR NK cell therapy)

    Recruiting
    • Relapsed/Refractory AML
    • +3 more
    • NKX101 - CAR NK cell therapy
    • Denver, Colorado
    • +6 more
    Apr 8, 2022

    AML, AML, Adult Trial in Indianapolis (TAK-659, Ixazomib)

    Terminated
    • AML
    • AML, Adult
    • Indianapolis, Indiana
      Indiana University Melvin and Bren Simon Cancer Center
    Mar 15, 2022

    AML, Adult, Chemo Effect Trial in Suzhou (Venetoclax, Decitabine for Injection, Cytarabine)

    Recruiting
    • AML, Adult
    • Chemotherapy Effect
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University, Jiangsu Ins
    Feb 28, 2022